Time-Course Changes in Biomarker Levels Observed in Effluent of Patients Administered Bicarbonate/Lactate-Buffered Neutral-pH Peritoneal Dialysis Fluid.

IF 2.2 3区 医学 Q3 HEMATOLOGY
Blood Purification Pub Date : 2026-01-01 Epub Date: 2026-02-10 DOI:10.1159/000550321
Risa Terashima, Nanae Matsuo, Yudo Tanno, Yukio Maruyama, Ichiro Ohkido, Takashi Yokoo
{"title":"Time-Course Changes in Biomarker Levels Observed in Effluent of Patients Administered Bicarbonate/Lactate-Buffered Neutral-pH Peritoneal Dialysis Fluid.","authors":"Risa Terashima, Nanae Matsuo, Yudo Tanno, Yukio Maruyama, Ichiro Ohkido, Takashi Yokoo","doi":"10.1159/000550321","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Biomarker levels in peritoneal dialysis (PD) effluent can predict the risks of inflammation, wasting, atherosclerosis, encapsulating peritoneal sclerosis, and mortality. However, assessments of biomarker variations associated with different dwell times and buffered solutions have yielded inconsistent results.</p><p><strong>Methods: </strong>This prospective crossover study examined 10 patients on PD to investigate changes in effluent biomarkers during a retention period of 8 h. Biomarker concentrations in bicarbonate lactate-buffered neutral-pH PD fluid (Bic/Lac PDF) effluent and those in lactate-buffered neutral-pH PD fluid (Lac PDF) effluent were compared.</p><p><strong>Results: </strong>Concentrations of urea nitrogen, creatinine, β2-microglobulin, and α1-microglobulin associated with Bic/Lac PDF and Lac PDF did not differ (analysis of variance [ANOVA]: p = 0.62, 0.25, 0.73, and 0.95, respectively). Differences in cancer antigen 125, interleukin-6, fibrin degradation products (FDP), vascular endothelial growth factor (VEGF), and tumor necrosis factor-α (TNF-α) were not observed (ANOVA: p = 0.81, 0.72, 0.66, 0.87, and 0.94, respectively). Additionally, concentrations of these biomarkers gradually increased over time from the start of PDF infusion until 8 h later; however, in some cases, FDP, VEGF, and TNF-α concentrations in effluent were below the detection limits at 2, 4, 6, and 8 h.</p><p><strong>Conclusion: </strong>A protective effect of Bic/Lac PDF on the peritoneal membrane was not observed. Biomarker concentrations in PD effluent gradually increased over time; however, some were below the detection limits during 8 h of retention. Assessments of biomarkers in effluent should be performed after an extended dwell time.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"315-322"},"PeriodicalIF":2.2000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000550321","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Biomarker levels in peritoneal dialysis (PD) effluent can predict the risks of inflammation, wasting, atherosclerosis, encapsulating peritoneal sclerosis, and mortality. However, assessments of biomarker variations associated with different dwell times and buffered solutions have yielded inconsistent results.

Methods: This prospective crossover study examined 10 patients on PD to investigate changes in effluent biomarkers during a retention period of 8 h. Biomarker concentrations in bicarbonate lactate-buffered neutral-pH PD fluid (Bic/Lac PDF) effluent and those in lactate-buffered neutral-pH PD fluid (Lac PDF) effluent were compared.

Results: Concentrations of urea nitrogen, creatinine, β2-microglobulin, and α1-microglobulin associated with Bic/Lac PDF and Lac PDF did not differ (analysis of variance [ANOVA]: p = 0.62, 0.25, 0.73, and 0.95, respectively). Differences in cancer antigen 125, interleukin-6, fibrin degradation products (FDP), vascular endothelial growth factor (VEGF), and tumor necrosis factor-α (TNF-α) were not observed (ANOVA: p = 0.81, 0.72, 0.66, 0.87, and 0.94, respectively). Additionally, concentrations of these biomarkers gradually increased over time from the start of PDF infusion until 8 h later; however, in some cases, FDP, VEGF, and TNF-α concentrations in effluent were below the detection limits at 2, 4, 6, and 8 h.

Conclusion: A protective effect of Bic/Lac PDF on the peritoneal membrane was not observed. Biomarker concentrations in PD effluent gradually increased over time; however, some were below the detection limits during 8 h of retention. Assessments of biomarkers in effluent should be performed after an extended dwell time.

给予碳酸氢盐/乳酸缓冲中性ph腹膜透析液的患者流出物中生物标志物水平的时间变化
腹膜透析(PD)流出物中的生物标志物水平可以预测炎症、消耗、动脉粥样硬化、包裹性腹膜硬化和死亡率的风险。然而,对与不同停留时间和缓冲溶液相关的生物标志物变化的评估产生了不一致的结果。方法:这项前瞻性交叉研究对10例PD患者进行了检查,以研究在8小时的滞留期间流出物生物标志物的变化。比较了碳酸氢盐缓冲中性ph PD液(Bic/Lac PDF)出水和乳酸缓冲中性ph PD液(Lac PDF)出水中生物标志物的浓度。结果:与Bic/Lac PDF和Lac PDF相关的尿素氮、肌酐、β2-微球蛋白和α1-微球蛋白浓度无显著差异(方差分析:p分别=0.62、0.25、0.73和0.95)。肿瘤抗原125、白细胞介素-6、纤维蛋白降解产物(FDP)、血管内皮生长因子(VEGF)和肿瘤坏死因子-α (TNF-α)未见差异(方差分析:p分别=0.81、0.72、0.66、0.87和0.94)。此外,这些生物标志物的浓度随着时间的推移逐渐增加,从开始输注PDF到8小时后;然而,在某些情况下,流出物中FDP、VEGF和TNF-α浓度在2、4、6和8小时时低于检测限。结论:Bic/Lac PDF对腹膜无保护作用。PD出水生物标志物浓度随时间逐渐升高;但保留8小时后仍有部分低于检出限。污水中生物标志物的评估应在延长停留时间后进行。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Blood Purification
Blood Purification 医学-泌尿学与肾脏学
CiteScore
5.80
自引率
3.30%
发文量
69
审稿时长
6-12 weeks
期刊介绍: Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书